Abstracts
Ehlers-Danlos syndrome (EDS) type IV, also known as vascular EDS, is an inherited connective tissue disorder with an estimated prevalence of 1/100,000 to 1/250,000. In EDS type IV, vascular complications may affect all anatomical areas, with a preference for large- and medium-sized arteries. Dissections of the vertebral and carotid arteries in their extra- and intra-cranial segments are typical. The authors report the case of a patient with EDS type IV for whom the diagnosis was established based on clinical signs and who developed internal carotid artery dissection at the age of 44 years. In the absence of a specific treatment for EDS type IV, medical interventions should focus on symptomatic relief, prophylactic measures, and genetic counseling. Invasive imaging techniques are contraindicated, and a conservative approach to vascular complications is usually recommended.
carotid artery; internal; dissection; Ehlers-Danlos syndrome; diagnosis; disease management
A síndrome de Ehlers-Danlos (EDS) tipo IV, também conhecida como EDS tipo vascular, é uma doença genética do tecido conjuntivo com prevalência estimada entre 1/100.000 e 1/250.000. Na EDS tipo IV, as complicações vasculares podem afetar todas as áreas anatômicas, com comprometimento preferencial de artérias de médio e grande diâmetros. Dissecções das artérias vertebrais e carótidas em seus segmentos intra e extracranianos são típicas. Os autores relatam o caso de uma paciente com EDS tipo IV na qual o diagnóstico sindrômico foi realizado com base nos achados clínicos e que desenvolveu dissecção da artéria carótida interna aos 44 anos. Na ausência de um tratamento específico para EDS tipo IV, a intervenção médica deve ser voltada para o tratamento sintomático, para medidas profiláticas e para o aconselhamento genético. Técnicas de imagem invasivas são contraindicadas e, geralmente, recomenda-se uma abordagem conservadora ao cuidar das complicações vasculares.
dissecção da artéria carótida interna; síndrome de Ehlers-Danlos; diagnóstico; manejo da doença
INTRODUCTION
Internal carotid artery (ICA) dissection is a condition that results from the
infiltration of blood into the vessel wall. It may affect the subintimal and medial
layers and lead to artery stenosis or occlusion, or the sub-adventitial layer, which
leads to aneurysm formation.11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
Dissections, which usually affect the superior cervical segment of the
extracranial ICA and the supraclinoid segment of its intracranial portion, are often
caused by trauma11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
. Other possible causes include fibromuscular dysplasia, fibroelastic changes of
the intima, cystic fibrosis of the media and connective tissue diseases, such as the
Ehlers-Danlos syndrome11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
.
The Ehlers-Danlos syndrome (EDS) comprises a heterogeneous set of at least 11 syndromes
with specific clinical and genetic characteristics resulting from defects in the
synthesis or the structure of several types of collagen22. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ.
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National
Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet.
1998;77(1):31-7.
http://dx.doi.org/10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O
http://dx.doi.org/10.1002/(SICI)1096-862...
. The vascular form of the disease is called EDS type IV, which is an inherited
dominant autosomal disorder caused by mutations in gene COL3A1, located
in 2q32.2, which encodes the pro-alpha 1 chain (III) of the fibrillar collagen type
III33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
4. Pepin MG, Byers PH. Ehlers-Danlos Syndrome Type IV. In: Pagon RA,
Bird TD, Dolan CR, et al., editors. GeneReviewsTM [Internet]. Seattle: University of
Washington; 1993. [atualizado 2011 maio 3; citado 2013 fev. 8].
http://www.ncbi.nlm.nih.gov/books/NBK1494/.
-
55. Online Mendelian Inheritance in Man - OMIM(r). [Internet]. Johns
Hopkins University, Baltimore, MD. MIM Number #130050. [atualizado 2012 out 2; citado
2013 fev. 8]. http://omim.org/entry/130050.
http://omim.org/entry/130050...
. The estimated prevalence of EDS type IV is about 1:100,000 to 1:250,000 in
the general population, and there is no ethnic or sex predilections33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
,
44. Pepin MG, Byers PH. Ehlers-Danlos Syndrome Type IV. In: Pagon RA,
Bird TD, Dolan CR, et al., editors. GeneReviewsTM [Internet]. Seattle: University of
Washington; 1993. [atualizado 2011 maio 3; citado 2013 fev. 8].
http://www.ncbi.nlm.nih.gov/books/NBK1494/.
.
Clinically, EDS type IV is characterized by important vascular involvement and a mean life expectancy of 48 years44. Pepin MG, Byers PH. Ehlers-Danlos Syndrome Type IV. In: Pagon RA, Bird TD, Dolan CR, et al., editors. GeneReviewsTM [Internet]. Seattle: University of Washington; 1993. [atualizado 2011 maio 3; citado 2013 fev. 8]. http://www.ncbi.nlm.nih.gov/books/NBK1494/.. Vascular complications may affect all anatomic areas, with a preference for large- and medium-sized arteries, and dissections of vertebral and carotid arteries in intra- and extracranial segments are typical events.
EDS type IV is very rare and physicians are not familiar with it. Therefore, the diagnosis is usually made after a catastrophic vascular complication or during autopsy44. Pepin MG, Byers PH. Ehlers-Danlos Syndrome Type IV. In: Pagon RA, Bird TD, Dolan CR, et al., editors. GeneReviewsTM [Internet]. Seattle: University of Washington; 1993. [atualizado 2011 maio 3; citado 2013 fev. 8]. http://www.ncbi.nlm.nih.gov/books/NBK1494/.. This report describes a case of EDS type IV in a patient whose most obvious clinical sign was hemiplegia due to spontaneous dissection of the internal carotid artery. The authors also discuss the diagnosis and management of this syndrome in this specific case.
CASE REPORT
A white, married, 44 years old, woman with no history of pregnacy was seen in the emergency department presenting with dysarthria, hemiplegia and hemiparesia of sudden onset in the upper and lower right extremities. Based on symptoms and imaging studies, a diagnosis of ischemic stroke (IS) was made, and she was treated conservatively in an intensive care unit for one week. After that time, she was discharged and started clinical follow-up with a vascular surgeon, who suspected a connective tissue congenital disease and referred the patient to a geneticist, who established the clinical diagnosis of EDS type IV.
Her family history was relevant, as her brother had a brain aneurysm diagnosed at 17 years, a maternal aunt had an ischemic stroke at 40-45 years, and her maternal grandmother died suddenly due to cardiac arrest at the age of 36 years. Her medical history included umbilical hernia surgery at 21 years of age, resection of uterine leiomyomata at 35 years of age, and operation of varicose veins in the lower limbs at 37 years.
Physical examination revealed a slender profile, thin facial features with deep-set eyes, thin lips, delicate and translucent skin, paucity of subcutaneous tissue, discrete signs of ageing (acrogeria) (Figure 1), loose ligaments in the hands, elbows and knees, negative Steinberg thumb sign and positive Walker-Murdoch wrist sign. Anthropometric data showed that her height was 176.5 cm (90th-97th percentile), arm span, 173.5 cm (arm span/height: 0.98), weight, 63 kg (50-75 p) and cranial circumference, 54.5 cm (50th-75 the percentile).
Patient in reported case. Thin facial features, thin lips, thin skin and paucity of subcutaneous tissue.
Color Doppler ultrasound showed a thin band a two-phase turbulent flow in left ICA, with hypoechoic material in its lumen filling more than 60% of the diameter of the segment evaluated (Figure 2).
Doppler ultrasound scan of carotid artery shows hyperechoic material in left ICA lumen (arrow) and narrow area of two-phase, turbulent flow (*).
She underwent magnetic resonance angiography (MRA) to examine cervical vessels, and results revealed stenosis of about 80% to 90% of the proximal segment of the left ICA, about 2.5 cm above its emergence (Figure 3).
The investigation continued by using other imaging methods and, because the patient was allergic to iodinated contrast, angiography with carbon dioxide was chosen. The scan showed an image compatible with an intimal flap in the bulbar portion of the left ICA and narrowing up to about the beginning of the petrous segment, findings associated with acute dissection of the left ICA. In addition, there was a saccular dilatation measuring 0.5 cm of diameter at about 1.5 cm from the carotid bifurcation, which was suggestive of a pseudoaneurysm (Figure 4).
Carbon dioxide angiogram shown narrowing of left ICA segment starting in bulbar region (*) and pseudoaneu rysm (arrow).
She has been followed up by a vascular surgeon in the outpatient service, and has been taking antiplatelet agents (clopidogrel, 75 mg/day). At every 6 months, she undergoes ultrasound scanning because of her bicuspid aortic valve; abdominal ultrasound to evaluate the abdominal aorta; and ultrasound scanning of the carotid arteries. She also undergoes treatment with a speech therapists and a physiotherapist due to the sequelae of the ischemic stroke. She was seen by a geneticist, underwent non-directive genetic counseling, and received information about prophylactic measures, risks associated with pregnancy and the clinical and inherited characteristics of EDS type IV.
DISCUSSION
The clinical diagnosis of EDS type IV is usually made according to the criteria defined
in 1997 during the Villefranche Conference66. Dwivedi AM, Hamdallah O, Morris ME, Yancey AE, Ross CB. Varying
presentations in patients with symptomatic type IV vascular Ehlers-Danlos syndrome.
Vasc Endovascular Surg. 2012;46(2):163-66. PMid:22308214.
http://dx.doi.org/10.1177/1538574411433298
http://dx.doi.org/10.1177/15385744114332...
7. Nakamura M, Yajima J, Oikawa Y, et al. Vascular Ehlers-Danlos
syndrome - all three coronary artery spontaneous dissections. J Cardiol. 2009; 53:
458-62. PMid:19477391. http://dx.doi.org/10.1016/j.jjcc.2008.09.007
http://dx.doi.org/10.1016/j.jjcc.2008.09...
8. Hampole CV, Philip F, Shafii A, et al. Spontaneous Coronary Artery
Dissection in Ehlers-Danlos syndrome. Ann Thorac Surg. 2011;92:1883-84.
PMid:22051286. http://dx.doi.org/10.1016/j.athoracsur.2011.03.136
http://dx.doi.org/10.1016/j.athoracsur.2...
-
99. Imamura A, Nakamoto H, Inoue T, et al. Ruptured dissecting aneurism
in bilateral iliac arteries caused by Ehlers-Danlos syndrome type IV: report of a
case. Surg Today. 2001;31:85-9. PMid:11213052.
http://dx.doi.org/10.1007/s005950170228
http://dx.doi.org/10.1007/s005950170228...
, shown in Table 1. The presence of
two or more major diagnostic criteria suggests the diagnosis, and biochemical or
molecular genetic tests should be performed for confirmation.22. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ.
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National
Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet.
1998;77(1):31-7.
http://dx.doi.org/10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O
http://dx.doi.org/10.1002/(SICI)1096-862...
Biochemical tests evaluate collagen type III by means of electrophoresis of
proteins in fibroblasts cultured in material collected for skin biopsy99. Imamura A, Nakamoto H, Inoue T, et al. Ruptured dissecting aneurism
in bilateral iliac arteries caused by Ehlers-Danlos syndrome type IV: report of a
case. Surg Today. 2001;31:85-9. PMid:11213052.
http://dx.doi.org/10.1007/s005950170228
http://dx.doi.org/10.1007/s005950170228...
. Molecular tests evaluate DNA directly, and include the complete sequencing of
the COL3A1 gene (reference criterion for laboratory investigation
because it detects 95% of the mutations that cause the disease44. Pepin MG, Byers PH. Ehlers-Danlos Syndrome Type IV. In: Pagon RA,
Bird TD, Dolan CR, et al., editors. GeneReviewsTM [Internet]. Seattle: University of
Washington; 1993. [atualizado 2011 maio 3; citado 2013 fev. 8].
http://www.ncbi.nlm.nih.gov/books/NBK1494/.) and the analysis of deletions and insertions more frequently associated with
the disease using different techniques, such as polymerase chain
reaction (PCR) and multiplex ligation-dependent probe
amplification (MLPA)1010. GeneTests Medical Genetics Information Resource [Internet].
Copyright, University of Washington, Seattle. 1993-2013. [citado 2013 fev. 8].
http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/clinical_disease_id/2067?db=genetests.
http://www.ncbi.nlm.nih.gov/sites/GeneTe...
.
In clinical practice, it is very difficult to perform genetic tests to confirm EDS type
IV. Currently, biochemical and molecular tests to identify EDS type IV are performed by
only 18 laboratories registered in GeneTests, an American site sponsored by the
National Center for Biotechnology Information (NCBI), an association
of international laboratories that conduct genetic tests approved by the Food
and Drug Administration (FDA)
1010. GeneTests Medical Genetics Information Resource [Internet].
Copyright, University of Washington, Seattle. 1993-2013. [citado 2013 fev. 8].
http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/clinical_disease_id/2067?db=genetests.
http://www.ncbi.nlm.nih.gov/sites/GeneTe...
. In Brazil, despite the National Comprehensive Health Care Policy for
Clinical Genetics of the Brazilian Unified Health System, most patients with genetic
diseases do not have access to medical geneticists or the necessary genetic testing1111. Melo DG, Sequeiros J. The challenges of incorporating genetic
testing in the unified national health system in Brazil. Genet Test Mol Biomarkers.
2012;16(7):651-5. PMid:22533694.
http://dx.doi.org/10.1089/gtmb.2011.0286
http://dx.doi.org/10.1089/gtmb.2011.0286...
. The patient in this case report had a clinical diagnosis because she met three
major criteria (thin and translucent skin, characteristic facial features and fragility
of arterial walls) and at least three minor criteria (joint hypermobility, early onset
of varicose veins and family history of sudden death), but she has not had access to
specific genetic tests to this date. An American study analyzed a series of 31 cases of
EDS type IV and found that 24 patients (77.3%) underwent biochemical tests, 11 (35.5%)
had molecular tests and 7 (22.7%) had a clinical diagnosis1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
.
The diagnosis of EDS type IV may be suggested by any ischemic stroke in a young
individual1313. Germain DP, Herrera-Guzman Y. Vascular Ehlers-Danlos syndrome. Ann
Genet. 2004;47(1):1-9. PMid:15127738.
http://dx.doi.org/10.1016/j.anngen.2003.07.002
http://dx.doi.org/10.1016/j.anngen.2003....
,
1414. Germain DP. The vascular Ehlers-Danlos syndrome. Curr Treat Options
Cardiovasc Med. 2006;8(2):121-27. PMid:16533486.
http://dx.doi.org/10.1007/s11936-006-0004-z
http://dx.doi.org/10.1007/s11936-006-000...
, as the syndrome is usually suspected only after vascular complications77. Nakamura M, Yajima J, Oikawa Y, et al. Vascular Ehlers-Danlos
syndrome - all three coronary artery spontaneous dissections. J Cardiol. 2009; 53:
458-62. PMid:19477391. http://dx.doi.org/10.1016/j.jjcc.2008.09.007
http://dx.doi.org/10.1016/j.jjcc.2008.09...
,
99. Imamura A, Nakamoto H, Inoue T, et al. Ruptured dissecting aneurism
in bilateral iliac arteries caused by Ehlers-Danlos syndrome type IV: report of a
case. Surg Today. 2001;31:85-9. PMid:11213052.
http://dx.doi.org/10.1007/s005950170228
http://dx.doi.org/10.1007/s005950170228...
. Intracranial hemorrhages affect 4% of the patients with EDS type IV, and
half of these cases are caused by the rupture of previously detected intracranial
aneurysms1515. Schievink WI. Cerebrovascular involvement in Ehlers-Danlos syndrome.
Curr Treat Options Cardiovasc Med. 2004;6(3):231-36. PMid:15096315.
http://dx.doi.org/10.1007/s11936-996-0018-6
http://dx.doi.org/10.1007/s11936-996-001...
. In a series of 31 patients with EDS type IV, 25% had complications that
affected the carotid arteries, and 2 patients had dissections1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
. ICA dissections are clinically characterized by a triad of headache (frontal,
orbital or peri-orbital), neck pain and partial ipsilateral Horner syndrome (ptosis and
myosis). However, carotid dissection is unilateral in most cases, and the patient rarely
presents with the classical triad11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
. About 50% to 95% of the patients with ICA dissection are estimated to have a
subsequent stroke. A Brazilian study with 48 patients conducted from 1997 to 2003 found
that the mean time interval from symptom onset to ischemic focal deficit was four to
five days1616. Campos CR, Evaristo EF, Yamamoto FJ, Puglia P Jr, Lucato LT, Scaff
M. Dissecção espontânea cervical carotídea e vertebral. Arq Neuropsiquiatr.
2004;62(2-B):492-98. PMid:15273850.
http://dx.doi.org/10.1590/S0004-282X2004000300021
http://dx.doi.org/10.1590/S0004-282X2004...
.
In cases of ICA dissection, the diagnosis of EDS type IV is important for the vascular
diagnosis and should define treatment. Defects in collagen type III synthesis make
patients highly susceptible to artery or vein ruptures that are difficult to repair
surgically99. Imamura A, Nakamoto H, Inoue T, et al. Ruptured dissecting aneurism
in bilateral iliac arteries caused by Ehlers-Danlos syndrome type IV: report of a
case. Surg Today. 2001;31:85-9. PMid:11213052.
http://dx.doi.org/10.1007/s005950170228
http://dx.doi.org/10.1007/s005950170228...
,
1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
. Therefore, invasive imaging studies33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
,
1717. De Paepe A, Malfait F. The Ehlers-Danlos syndrome, a disorder with
many faces. Clin Genet 2012;82:1-11. PMid:22353005.
http://dx.doi.org/10.1111/j.1399-0004.2012.01858.x
http://dx.doi.org/10.1111/j.1399-0004.20...
, such as intra-arterial digital subtraction angiography, the reference
standard in the investigation of ICA dissection11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
,
1818. Pieri A, Spitz M, Valiente RA, Avelar WM, Silva GS, Massaro AR.
Dissecção espontânea das artérias carótidas e vertebrais em uma população
multiétnica. Arq Neuropsiquiatr. 2007;65(4-A):1050-55. PMid:18094876.
http://dx.doi.org/10.1590/S0004-282X2007000600029
http://dx.doi.org/10.1590/S0004-282X2007...
, are contraindicated. Several non-invasive vascular imaging techniques may
be helpful in establishing a diagnosis: extracranial and transcranial Doppler ultrasound
and color-coded duplex ultrasound; computed tomography (CT); magnetic resonance (MR);
and magnetic resonance angiography (MRA). Ultrasound studies have a joint sensitivity of
95%, but are limited for the visualization of distal ICA dissections. MRI and MRA
provide better visualization of morphology and blood flow in the carotid arteries, but
also have disadvantages, such as a tendency to overestimate the degree of stenosis, the
production of artifacts due to swallowing or patient movements, and a lower capacity to
detect acute hematomas11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
,
1616. Campos CR, Evaristo EF, Yamamoto FJ, Puglia P Jr, Lucato LT, Scaff
M. Dissecção espontânea cervical carotídea e vertebral. Arq Neuropsiquiatr.
2004;62(2-B):492-98. PMid:15273850.
http://dx.doi.org/10.1590/S0004-282X2004000300021
http://dx.doi.org/10.1590/S0004-282X2004...
,
1818. Pieri A, Spitz M, Valiente RA, Avelar WM, Silva GS, Massaro AR.
Dissecção espontânea das artérias carótidas e vertebrais em uma população
multiétnica. Arq Neuropsiquiatr. 2007;65(4-A):1050-55. PMid:18094876.
http://dx.doi.org/10.1590/S0004-282X2007000600029
http://dx.doi.org/10.1590/S0004-282X2007...
. When combined, non-invasive vascular imaging studies are the best option for
patients with EDS type IV33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
,
1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
,
1717. De Paepe A, Malfait F. The Ehlers-Danlos syndrome, a disorder with
many faces. Clin Genet 2012;82:1-11. PMid:22353005.
http://dx.doi.org/10.1111/j.1399-0004.2012.01858.x
http://dx.doi.org/10.1111/j.1399-0004.20...
.
In the case reported here, Doppler ultrasound, MRA and carbon dioxide angiography
confirmed ICA dissection, and the patient did not have to undergo surgery. Studies in
the literature suggest that the risk of weakening arterial walls during surgery is high
because of the fragility of vessels in patients with EDS type IV. Standard vascular
sutures usually lead to tearing, and the best choices for these patients are arterial
ligatures, as long as they do not compromise the blood supply to the organ, or a carotid
bypass. Other precautions include the delicate and atraumatic handling of the artery and
the use of soft, coated clamps or occlusion balloons instead of standard clamps11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
,
33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
,
99. Imamura A, Nakamoto H, Inoue T, et al. Ruptured dissecting aneurism
in bilateral iliac arteries caused by Ehlers-Danlos syndrome type IV: report of a
case. Surg Today. 2001;31:85-9. PMid:11213052.
http://dx.doi.org/10.1007/s005950170228
http://dx.doi.org/10.1007/s005950170228...
,
1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
. However, no conclusive data about the use of stents are available1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
.
In general, patients that had spontaneous ICA dissection should receive prolonged
anticoagulation treatment with heparin and warfarin for 3 to 6 months to prevent
artery-to-artery embolism, and the treatment should be discontinued when there is full
arterial recanalization11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
,
1616. Campos CR, Evaristo EF, Yamamoto FJ, Puglia P Jr, Lucato LT, Scaff
M. Dissecção espontânea cervical carotídea e vertebral. Arq Neuropsiquiatr.
2004;62(2-B):492-98. PMid:15273850.
http://dx.doi.org/10.1590/S0004-282X2004000300021
http://dx.doi.org/10.1590/S0004-282X2004...
. In a small percentage of cases, recanalization is not achieved after six
months, and surgical revascularization may be used11. Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas
2008;16(3): 353-61.
http://dx.doi.org/10.1590/S2179-83972008000300018
http://dx.doi.org/10.1590/S2179-83972008...
. In patients with EDS type IV, treatment should be conservative whenever
possible, and surgery should be limited to unavoidable, life-threatening situations33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
,
1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
,
1717. De Paepe A, Malfait F. The Ehlers-Danlos syndrome, a disorder with
many faces. Clin Genet 2012;82:1-11. PMid:22353005.
http://dx.doi.org/10.1111/j.1399-0004.2012.01858.x
http://dx.doi.org/10.1111/j.1399-0004.20...
. Minimally symptomatic aneurysms should not be operated on electively unless
there are signs of rapid expansion and imminent rupture1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
. Patients with aneurysms treated conservatively should be examined at intervals
of 3 to 6 months using non-invasive vascular imaging techniques1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
. When there is no aneurysm, the usefulness of routine vascular screening is
controversial33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
, but some authors recommend a yearly follow-up visit for a careful physical
examination, echocardiogram, carotid and abdominal ultrasound, as well as chest and
abdominal CT and MRI in case there are incidental findings33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
,
1212. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management
and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc
Surg. 2005;42:98-106. PMid:16012458.
http://dx.doi.org/10.1016/j.jvs.2005.03.053
http://dx.doi.org/10.1016/j.jvs.2005.03....
.
Several studies have compared anticoagulants and antiplatelet agents for cases of
cervical artery dissections, and both medications seem to have similar results1919. Kennedy F, Lanfranconi S, Hicks C, et al. Antiplatelets vs
anticoagulation for dissection. Neurology. 2012;79:686-89. PMid:22855862.
http://dx.doi.org/10.1212/WNL.0b013e318264e36b
http://dx.doi.org/10.1212/WNL.0b013e3182...
. Additionally, a recent multicenter study with patients with EDS type IV showed
that the use of celiprolol, a β(1)-adrenoceptor antagonist with a β(2)-adrenoceptor
agonist action, reduces the incidence of dissection or arterial ruptures threefold2020. Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on
prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective
randomised, open, blinded-endpoints trial. Lancet. 2010; 376(9751):1476-84.
http://dx.doi.org/10.1016/S0140-6736(10)60960-9. Although celiprolol was approved for use in Brazil in 1996,2121. Brasil. Ministério da Saúde. Portaria no. 1.179, de 17 de junho de
1996. [Internet]. [citado 2013 abr. 4].
http://www.pharmanet.com.br/legisla/port1179.htm.
http://www.pharmanet.com.br/legisla/port...
it is not easily found in the market in this country2222. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de
Hipertensão, Sociedade Brasileira de Nefrologia. Tratamento Medicamentoso. VI
Diretrizes Brasileiras de Hipertensão. Arq. Bras. Cardiol.
2010;95(Supl.1):1-51., and it is usually imported, which complicates its use by patients.
Specifically, the clinical management of patients with EDS type IV should include the
adoption of general prophylactic measures: the elimination of intense physical activity,
violent sports or diving; the awareness of the vascular risks of pregnancy (maternal
death is about 12%); and, ideally, the use of contraception33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
. As EDS type IV is an autosomal dominant trait, patients should receive genetic
counseling and be aware that the risk of recurrence for their offspring is 50%33. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007;2:32. PMid:17640391 PMCid:1971255.
http://dx.doi.org/10.1186/1750-1172-2-32
http://dx.doi.org/10.1186/1750-1172-2-32...
4. Pepin MG, Byers PH. Ehlers-Danlos Syndrome Type IV. In: Pagon RA,
Bird TD, Dolan CR, et al., editors. GeneReviewsTM [Internet]. Seattle: University of
Washington; 1993. [atualizado 2011 maio 3; citado 2013 fev. 8].
http://www.ncbi.nlm.nih.gov/books/NBK1494/.
-
55. Online Mendelian Inheritance in Man - OMIM(r). [Internet]. Johns
Hopkins University, Baltimore, MD. MIM Number #130050. [atualizado 2012 out 2; citado
2013 fev. 8]. http://omim.org/entry/130050.
http://omim.org/entry/130050...
.
CONCLUSION
Vascular surgeons should keep in mind the possibility of EDS type IV and its severe vascular complications. Patients with this disease require special care before, during and after operation.
The authors thank the patient for the permission to report on her case.
REFERENCES
-
1Chaves C. Dissecção da artéria carótida. Rev Bras Cardiol Invas 2008;16(3): 353-61. http://dx.doi.org/10.1590/S2179-83972008000300018
» http://dx.doi.org/10.1590/S2179-83972008000300018 -
2Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998;77(1):31-7. http://dx.doi.org/10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O
» http://dx.doi.org/10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O -
3Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis. 2007;2:32. PMid:17640391 PMCid:1971255. http://dx.doi.org/10.1186/1750-1172-2-32
» http://dx.doi.org/10.1186/1750-1172-2-32 -
4Pepin MG, Byers PH. Ehlers-Danlos Syndrome Type IV. In: Pagon RA, Bird TD, Dolan CR, et al., editors. GeneReviewsTM [Internet]. Seattle: University of Washington; 1993. [atualizado 2011 maio 3; citado 2013 fev. 8]. http://www.ncbi.nlm.nih.gov/books/NBK1494/.
-
5Online Mendelian Inheritance in Man - OMIM(r). [Internet]. Johns Hopkins University, Baltimore, MD. MIM Number #130050. [atualizado 2012 out 2; citado 2013 fev. 8]. http://omim.org/entry/130050.
» http://omim.org/entry/130050 -
6Dwivedi AM, Hamdallah O, Morris ME, Yancey AE, Ross CB. Varying presentations in patients with symptomatic type IV vascular Ehlers-Danlos syndrome. Vasc Endovascular Surg. 2012;46(2):163-66. PMid:22308214. http://dx.doi.org/10.1177/1538574411433298
» http://dx.doi.org/10.1177/1538574411433298 -
7Nakamura M, Yajima J, Oikawa Y, et al. Vascular Ehlers-Danlos syndrome - all three coronary artery spontaneous dissections. J Cardiol. 2009; 53: 458-62. PMid:19477391. http://dx.doi.org/10.1016/j.jjcc.2008.09.007
» http://dx.doi.org/10.1016/j.jjcc.2008.09.007 -
8Hampole CV, Philip F, Shafii A, et al. Spontaneous Coronary Artery Dissection in Ehlers-Danlos syndrome. Ann Thorac Surg. 2011;92:1883-84. PMid:22051286. http://dx.doi.org/10.1016/j.athoracsur.2011.03.136
» http://dx.doi.org/10.1016/j.athoracsur.2011.03.136 -
9Imamura A, Nakamoto H, Inoue T, et al. Ruptured dissecting aneurism in bilateral iliac arteries caused by Ehlers-Danlos syndrome type IV: report of a case. Surg Today. 2001;31:85-9. PMid:11213052. http://dx.doi.org/10.1007/s005950170228
» http://dx.doi.org/10.1007/s005950170228 -
10GeneTests Medical Genetics Information Resource [Internet]. Copyright, University of Washington, Seattle. 1993-2013. [citado 2013 fev. 8]. http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/clinical_disease_id/2067?db=genetests.
» http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/clinical_disease_id/2067?db=genetests. -
11Melo DG, Sequeiros J. The challenges of incorporating genetic testing in the unified national health system in Brazil. Genet Test Mol Biomarkers. 2012;16(7):651-5. PMid:22533694. http://dx.doi.org/10.1089/gtmb.2011.0286
» http://dx.doi.org/10.1089/gtmb.2011.0286 -
12Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience. J Vasc Surg. 2005;42:98-106. PMid:16012458. http://dx.doi.org/10.1016/j.jvs.2005.03.053
» http://dx.doi.org/10.1016/j.jvs.2005.03.053 -
13Germain DP, Herrera-Guzman Y. Vascular Ehlers-Danlos syndrome. Ann Genet. 2004;47(1):1-9. PMid:15127738. http://dx.doi.org/10.1016/j.anngen.2003.07.002
» http://dx.doi.org/10.1016/j.anngen.2003.07.002 -
14Germain DP. The vascular Ehlers-Danlos syndrome. Curr Treat Options Cardiovasc Med. 2006;8(2):121-27. PMid:16533486. http://dx.doi.org/10.1007/s11936-006-0004-z
» http://dx.doi.org/10.1007/s11936-006-0004-z -
15Schievink WI. Cerebrovascular involvement in Ehlers-Danlos syndrome. Curr Treat Options Cardiovasc Med. 2004;6(3):231-36. PMid:15096315. http://dx.doi.org/10.1007/s11936-996-0018-6
» http://dx.doi.org/10.1007/s11936-996-0018-6 -
16Campos CR, Evaristo EF, Yamamoto FJ, Puglia P Jr, Lucato LT, Scaff M. Dissecção espontânea cervical carotídea e vertebral. Arq Neuropsiquiatr. 2004;62(2-B):492-98. PMid:15273850. http://dx.doi.org/10.1590/S0004-282X2004000300021
» http://dx.doi.org/10.1590/S0004-282X2004000300021 -
17De Paepe A, Malfait F. The Ehlers-Danlos syndrome, a disorder with many faces. Clin Genet 2012;82:1-11. PMid:22353005. http://dx.doi.org/10.1111/j.1399-0004.2012.01858.x
» http://dx.doi.org/10.1111/j.1399-0004.2012.01858.x -
18Pieri A, Spitz M, Valiente RA, Avelar WM, Silva GS, Massaro AR. Dissecção espontânea das artérias carótidas e vertebrais em uma população multiétnica. Arq Neuropsiquiatr. 2007;65(4-A):1050-55. PMid:18094876. http://dx.doi.org/10.1590/S0004-282X2007000600029
» http://dx.doi.org/10.1590/S0004-282X2007000600029 -
19Kennedy F, Lanfranconi S, Hicks C, et al. Antiplatelets vs anticoagulation for dissection. Neurology. 2012;79:686-89. PMid:22855862. http://dx.doi.org/10.1212/WNL.0b013e318264e36b
» http://dx.doi.org/10.1212/WNL.0b013e318264e36b -
20Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010; 376(9751):1476-84. http://dx.doi.org/10.1016/S0140-6736(10)60960-9
-
21Brasil. Ministério da Saúde. Portaria no. 1.179, de 17 de junho de 1996. [Internet]. [citado 2013 abr. 4]. http://www.pharmanet.com.br/legisla/port1179.htm.
» http://www.pharmanet.com.br/legisla/port1179.htm -
22Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia. Tratamento Medicamentoso. VI Diretrizes Brasileiras de Hipertensão. Arq. Bras. Cardiol. 2010;95(Supl.1):1-51.
-
Conception and design: MN, DGMAnalysis and interpretation: MN, MBV, LGAP, AIN, DGMData collection: MBV, LGAP, AINWriting the article: MN, MBV, LGAP, AIN, DGMCritical revision of the article: MN, DGMFinal approval of the article*: MN, MBV, LGAP, AIN, DGMStatistical analysis: N/AOverall responsibility: MN
-
Financial support: None.
-
*All authors should have read and approved of the final version of the article submitted to J Vasc Bras.
-
The study was carried out at the Department of Medicine of Universidade Federal de São Carlos (UFSCar), São Carlos, SP, Brazil.
Publication Dates
-
Publication in this collection
June 2013
History
-
Received
03 Jan 2013 -
Accepted
04 Apr 2013